cAMP/PKA-mediated Regulation of Erythropoiesis

References

• White, L., Fisher, J.W. and George, W.J. (1980) "Role of erythropoietin and cyclic nucleotides in erythroid cell proliferation in fetal liver", Exp. Hematol. 8\(Suppl. 8), 168�181.
   PubMed Web of Science ®Google Scholar
• Bonanou-Tzedaki, S.A., Setchenska, M.S. and Arnstein, H.R. (1986) "Stimulation of the adenylate cyclase activity of rabbit bone marrow immature erythroblasts by erythropoietin and haemin", Eur. J. Biochem. 155, 363–370.
   PubMedGoogle Scholar
• Kuramochi, S., Sugimoto, Y., Ikawa, Y. and Todokoro, K. (1990) "Transmembrane signaling during erythropoietin- and dimethylsulfoxide- induced erythroid cell differentiation", Eur. J. Biochem. 193, 163–168.
   PubMedGoogle Scholar
• Graber, S.E., Bomboy, J.D. Jr, Salmon, W.D. Jr and Krantz, S.B. (1979) "Evidence that endotoxin is the cyclic 30:50-GMPpromoting factor in erythropoietin preparations", J. Lab. Clin. Med. 93, 25–31.
   PubMed Web of Science ®Google Scholar
• Belegu, M., Beckman, B. and Fisher, J.W. (1983) "beta- Adrenergic blockade of prostaglandin E2- and D2-induced erythroid colony formation", Am. J. Physiol. 245, C322–C327.
   PubMed Web of Science ®Google Scholar
• Fisher, J.W., Radtke, H.W., Jubiz,W., Nelson, P.K. and Burdowski, A. (1980) "Prostaglandins activation of erythropoietin production and erythroid progenitor cells", Exp. Hematol. 8\(Suppl. 8), 65–89.
   PubMed Web of Science ®Google Scholar
• Rossi, G.B., Migliaccio, A.R., Migliaccio, G., Lettieri, F., Di Rosa, M., Peschle, C. and Mastroberardino, G. (1980) "In vitro interactions of PGE and cAMP with murine and human erythroid precursors", Blood 56, 74–79.
   PubMed Web of Science ®Google Scholar
• Pelus, L.M. and Gentile, P.S. (1988) "In vivo modulation of myelopoiesis by prostaglandin E2. III. Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation", Blood 71, 1633–1640.
   PubMed Web of Science ®Google Scholar
• Hurley, J.H. (1999) "Structure, mechanism, and regulation of mammalian adenylyl cyclase", J. Biol. Chem. 274, 7599–7602.
   PubMed Web of Science ®Google Scholar
• Defer, N., Best-Belpomme, M. and Hanoune, J. (2000) "Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase", Am. J. Physiol. Renal Physiol. 279, F400–F416.
   PubMed Web of Science ®Google Scholar
• Patel, T.B., Du, Z., Pierre, S., Cartin, L. and Scholich, K. (2001) "Molecular biological approaches to unravel adenylyl cyclase signaling and function", Gene 269, 13–25.
   PubMed Web of Science ®Google Scholar
• Haslauer, M., Baltensperger, K. and Porzig, H. (1998) "Thrombin and phorbol esters potentiate Gs-mediated cAMP formation in intact human erythroid progenitors via two synergistic signaling pathways converging on adenylyl cyclase type VII", Mol. Pharmacol. 53, 837–845.
   PubMed Web of Science ®Google Scholar
• Ichikawa, A., Sugimoto, Y. and Negishi, M. (1996) "Molecular aspects of the structures and functions of the prostaglandin E receptors", J. Lipid Mediat. Cell Signal. 14, 83–87.
   PubMedGoogle Scholar
• Li, D.M. and Sun, H. (1997) "TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta", Cancer Res. 57, 2124–2129.
   PubMed Web of Science ®Google Scholar
• Setchenska, M.S. (1990) "Adenylate cyclase system of differentiating erythroid cells", Acta Physiol. Pharmacol. Bulg. 16, 3–10.
   PubMedGoogle Scholar
• Porzig, H., Gutknecht, R., Kostova, G. and Thalmeier, K. (1995) "G-protein-coupled receptors in normal human erythroid progenitor cells", Naunyn Schmiedebergs Arch. Pharmacol. 353, 11–20.
   PubMed Web of Science ®Google Scholar
• Hendrie, P.C. and Broxmeyer, H.E. (1994) "Myeloid cell proliferation stimulated by Steel factor is pertussis toxin sensitive and enhanced by cholera toxin", Int. J. Immunopharmacol. 16, 547–560.
   PubMed Web of Science ®Google Scholar
• Guillard, C., Chretien, S., Jockers, R., Fichelson, S., Mayeux, P. and Duprez, V. (2001) "Coupling of heterotrimeric Gi proteins to the erythropoietin receptor", J. Biol. Chem. 276, 2007–2014.
   PubMed Web of Science ®Google Scholar
• Francis, S.H., Turko, I.V. and Corbin, J.D. (2001) "Cyclic nucleotide phosphodiesterases: relating structure and function", Prog. Nucleic Acid. Res. Mol. Biol. 65, 1–52.
   PubMed Web of Science ®Google Scholar
• Soderling, S.H. and Beavo, J.A. (2000) "Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions", Curr. Opin. Cell Biol. 12, 174–179.
   PubMed Web of Science ®Google Scholar
• Perry, S.J., Baillie, G.S., Kohout, T.A., McPhee, I., Magiera, M.M., Ang, K.L., Miller, W.E., McLean, A.J., Conti, M., Houslay, M.D. and Lefkowitz, R.J. (2002) "Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins", Science 298, 834–836.
   PubMed Web of Science ®Google Scholar
• Hanoune, J. and Defer, N. (2001) "Regulation and role of adenylyl cyclase isoforms", Annu. Rev. Pharmacol. Toxicol. 41, 145–174.
   PubMed Web of Science ®Google Scholar
• Nakamura, T. and Gold, G.H. (1987) "A cyclic nucleotide-gated conductance in olfactory receptor cilia", Nature 325, 442–444.
   PubMed Web of Science ®Google Scholar
• DiFrancesco, D. and Tortora, P. (1991) "Direct activation of cardiac pacemaker channels by intracellular cyclic AMP", Nature 351, 145–147.
   PubMed Web of Science ®Google Scholar
• de Rooij, J., Zwartkruis, F.J., Verheijen, M.H., Cool, R.H., Nijman, S.M., Wittinghofer, A. and Bos, J.L. (1998) "Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP", Nature 396, 474–477.
   PubMed Web of Science ®Google Scholar
• Parker, D., Ferreri, K., Nakajima, T., LaMorte, V.J., Evans, R., Koerber, S.C., Hoeger, C. and Montminy, M.R. (1996) "Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism", Mol. Cell Biol. 16, 694–703.
   PubMed Web of Science ®Google Scholar
• Gonzalez, G.A., Montminy, M.R. and Cyclic, A.M.P. (1989) "stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133", Cell 59, 675–680.
   PubMed Web of Science ®Google Scholar
• Casteel, D., Suhasini, M., Gudi, T., Naima, R. and Pilz, R.B. (1998) "Regulation of the erythroid transcription factor NF-E2 by cyclic adenosine monophosphate-dependent protein kinase", Blood 91, 3193–3201.
   PubMed Web of Science ®Google Scholar
• Janknecht, R., Monte, D., Baert, J.L. and de Launoit, Y. (1996) "The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA", Oncogene 13, 1745–1754.
   PubMed Web of Science ®Google Scholar
• Rohlff, C., Ahmad, S., Borellini, F., Lei, J. and Glazer, R.I. (1997) "Modulation of transcription factor Sp1 by cAMP-dependent protein kinase", J. Biol. Chem. 272, 21137–21141.
   PubMed Web of Science ®Google Scholar
• Garcia, M.A., Campillos, M., Marina, A., Valdivieso, F. and Vazquez, J. (1999) "Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation", FEBS Lett. 444, 27–31.
   PubMed Web of Science ®Google Scholar
• Pilz, R.B. (1993) "Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells", J. Biol. Chem. 268, 20252–20258.
   PubMed Web of Science ®Google Scholar
• Engh, R.A., Girod, A., Kinzel, V., Huber, R. and Bossemeyer, D. (1996) "Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity", J. Biol. Chem. 271, 26157–26164.
   PubMed Web of Science ®Google Scholar
• Skalhegg, B.S. and Tasken, K. (2000) "Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation and subcellular localization of subunits of PKA", Front Biosci. 5, D678–D693.
   PubMed Web of Science ®Google Scholar
• Schwartz, J.H. (2001) "The many dimensions of cAMP signaling", Proc. Natl Acad. Sci. USA 98, 13482–13484.
   PubMed Web of Science ®Google Scholar
• Johnson, D.A., Akamine, P., Radzio-Andzelm, E., Madhusudan, M. and Taylor, S.S. (2001) "Dynamics of cAMP-dependent protein kinase", Chem. Rev. 101, 2243–2270.
   PubMed Web of Science ®Google Scholar
• Greenberg, S.M., Castellucci, V.F., Bayley, H. and Schwartz, J.H. (1987) "A molecular mechanism for long-term sensitization in Aplysia", Nature 329, 62–65.
   PubMed Web of Science ®Google Scholar
• Schwartz, J.H. and Greenberg, S.M. (1987) "Molecular mechanisms for memory: second-messenger induced modifications of protein kinases in nerve cells", Annu. Rev. Neurosci. 10, 459–476.
   PubMed Web of Science ®Google Scholar
• Muller, U. and Carew, T.J. (1998) "Serotonin induces temporally and mechanistically distinct phases of persistent PKA activity in Aplysia sensory neurons", Neuron 21, 1423–1434.
   PubMed Web of Science ®Google Scholar
• Srivastava, R.K., Lee, Y.N., Noguchi, K., Park, Y.G., Ellis, M.J., Jeong, J.S., Kim, S.N. and Cho-Chung, Y.S. (1998) "The RIIbeta regulatory subunit of protein kinase A binds to cAMP response element: an alternative cAMP signaling pathway", Proc. Natl Acad. Sci. USA 95, 6687–6692.
   PubMed Web of Science ®Google Scholar
• Tsuda, H., Sawada, T., Sakaguchi, M., Kawakita, M. and Takatsuki, K. (1989) "Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. I. Involvement of adenosine 30,50-cyclic monophosphate not as a second messenger but as a regulator of cell growth", Exp. Hematol. 17, 211–217.
   PubMed Web of Science ®Google Scholar
• Datta, M.C. (1985) "Prostaglandin E2 mediated effects on the synthesis of fetal and adult hemoglobin in blood erythroid bursts", Prostaglandins 29, 561–577.
   PubMed Web of Science ®Google Scholar
• Fisher, J.W. and Hagiwara, M. (1984) "Effects of prostaglandins on erythropoiesis", Blood Cells 10, 241–260.
   PubMedGoogle Scholar
• Liao, H.J., Kume, T., Mckay, C., Xu, M.J., Ihle, J.N. and Carpenter, G. (2002) "Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice", J. Biol. Chem. 277, 9335–9341.
   PubMed Web of Science ®Google Scholar
• Lawson, A.E., Bao, H., Wickrema, A., Jacobs-Helber, S.M. and Sawyer, S.T. (2000) "Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietindependent HCD57 cells", Blood 96, 2084–2092.
   PubMed Web of Science ®Google Scholar
• Sui, X., Krantz, S.B. and Zhao, Z.J. (2000) "Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways", Br. J. Haematol. 110, 63–70.
   PubMed Web of Science ®Google Scholar
• Kang, C.D., Do, I.R., Kim, K.W., Ahn, B.K., Kim, S.H., Chung, B.S., Jhun, B.H. and Yoo, M.A. (1999) "Role of Ras/ERKdepending pathway in the erythroid differentiation of K562 cells", Exp. Mol. Med. 31, 76–82.
   PubMed Web of Science ®Google Scholar
• Uchida, M., Kirito, K., Shimizu, R., Miura, Y., Ozawa, K. and Komatsu, N. (2001) "A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages", Int. J. Hematol. 73, 78–83.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, T., Aisaki, K., Yamamura, Y., Noda, M. and Ikawa, Y. (2000) "Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line", Oncogene 19, 1500–1508.
   PubMed Web of Science ®Google Scholar
• Muta, K., Krantz, S.B., Bondurant, M.C. and Dai, C.H. (1995) "Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation", Blood 86, 572–580.
   PubMed Web of Science ®Google Scholar
• Muta, K. and Krantz, S.B. (1995) "Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells", J. Cell Physiol. 163, 38–50.
   PubMed Web of Science ®Google Scholar
• Kerkhoff, E. and Rapp, U.R. (1998) "Cell cycle targets of Ras/Raf signalling", Oncogene 17, 1457–1462.
   PubMed Web of Science ®Google Scholar
• Erickson-Miller, C.L., Pelus, L.M. and Lord, K.A. (2000) "Signaling induced by erythropoietin and stem cell factor in UT- 7/Epo cells: transient versus sustained proliferation", Stem Cells 18, 366–373.
   PubMed Web of Science ®Google Scholar
• Fabian, J.R., Daar, I.O. and Morrison, D.K. (1993) "Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase", Mol. Cell Biol. 13, 7170–7179.
   PubMed Web of Science ®Google Scholar
• Mason, C.S., Springer, C.J., Cooper, R.G., Superti-Furga, G., Marshall, C.J. and Marais, R. (1999) "Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation", EMBO J. 18, 2137–2148.
   PubMed Web of Science ®Google Scholar
• Vossler, M.R., Yao, H., York, R.D., Pan, M.G., Rim, C.S. and Stork, P.J. (1997) "cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway", Cell 89, 73–82.
   PubMed Web of Science ®Google Scholar
• Garcia, J., de Gunzburg, J., Eychene, A., Gisselbrecht, S. and Porteu, F. (2001) "Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways", Mol. Cell Biol. 21, 2659–2670.
   PubMed Web of Science ®Google Scholar
• Guo, F.F., Kumahara, E. and Saffen, D. (2001) "A CalDAGGEFI/ Rap1/B-Raf cassette couples M(1) muscarinic acetylcholine receptors to the activation of ERK1/2", J. Biol. Chem. 276, 25568–25581.
   PubMed Web of Science ®Google Scholar
• Bolger, G.B., Erdogan, S., Jones, R.E., Loughney, K., Scotland, G., Hoffmann, R., Wilkinson, I., Farrell, C. and Houslay, M.D. (1997) "Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene", Biochem. J. 328\(Pt 2), 539–548.
   PubMed Web of Science ®Google Scholar
• Hoffmann, R., Wilkinson, I.R., McCallum, J.F., Engels, P. and Houslay, M.D. (1998) "cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model", Biochem. J. 333\(Pt 1), 139–149.
   PubMed Web of Science ®Google Scholar
• MacKenzie, S.J., Baillie, G.S., McPhee, I., Bolger, G.B. and Houslay, M.D. (2000) "ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMPspecific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions", J. Biol. Chem. 275, 16609–16617.
   PubMed Web of Science ®Google Scholar
• Socolovsky, M., Nam, H., Fleming, M.D., Haase, V.H., Brugnara, C. and Lodish, H.F. (2001) "Ineffective erythropoiesis in Stat5a(2/2)5b(2/2) mice due to decreased survival of early erythroblasts", Blood 98, 3261–3273.
   PubMed Web of Science ®Google Scholar
• Damen, J.E.,Wakao, H., Miyajima, A., Krosl, J., Humphries, R.K., Cutler, R.L. and Krystal, G. (1995) "Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation", EMBO J. 14, 5557–5568.
   PubMed Web of Science ®Google Scholar
• Gobert, S., Chretien, S., Gouilleux, F., Muller, O., Pallard, C., Dusanter-Fourt, I., Groner, B., Lacombe, C., Gisselbrecht, S. and Mayeux, P. (1996) "Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation", EMBO J. 15, 2434–2441.
   PubMed Web of Science ®Google Scholar
• Quelle, F.W., Wang, D., Nosaka, T., Thierfelder, W.E., Stravopodis, D., Weinstein, Y. and Ihle, J.N. (1996) "Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response", Mol. Cell Biol. 16, 1622–1631.
   PubMed Web of Science ®Google Scholar
• Klingmuller, U., Bergelson, S., Hsiao, J.G. and Lodish, H.F. (1996) "Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5", Proc. Natl Acad. Sci. USA 93, 8324–8328.
   PubMed Web of Science ®Google Scholar
• Boucheron, C., Dumon, S., Santos, S.C., Moriggl, R., Hennighausen, L., Gisselbrecht, S. and Gouilleux, F. (1998) "A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities", J. Biol. Chem. 273, 33936–33941.
   PubMed Web of Science ®Google Scholar
• Grimley, P.M., Dong, F. and Rui, H. (1999) "Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation", Cytokine Growth Factor Rev. 10, 131–157.
   PubMed Web of Science ®Google Scholar
• Boer, A.K., Drayer, A.L., Rui, H. and Vellenga, E. (2002) "Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB", Blood 100, 467–473.
   PubMed Web of Science ®Google Scholar
• Boer, A.K., Drayer, A.L. and Vellenga, E. (2003) "Stem cell factor primes erythropoietin-mediated transactivation of signal transducer and activator of transcription 5 (STAT5) via the PKA/CREB pathway", Exp. Hematol., in press.
   Google Scholar
• Kasper, L.H., Boussouar, F., Ney, P.A., Jackson, C.W., Rehg, J., van Deursen, J.M. and Brindle, P.K. (2002) "A transcriptionfactor- binding surface of coactivator p300 is required for haematopoiesis", Nature 419(6908), 738–743.
   PubMed Web of Science ®Google Scholar
• Oike, Y., Takakura, N., Hata, A., Kaname, T., Akizuki, M., Yamaguchi, Y., Yasue, H., Araki, K., Yamamura, K. and Suda, T. (1999) "Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis", Blood 93, 2771–2779.
   PubMed Web of Science ®Google Scholar
• Blobel, G.A. (2002) "CBP and p300: versatile coregulators with important roles in hematopoietic gene expression", J. Leukoc. Biol. 71, 545–556.
   PubMed Web of Science ®Google Scholar
• Sadlon, T.J., Dell'Oso, T., Surinya, K.H. and May, B.K. (1999) "Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis", Int. J. Biochem. Cell Biol. 31, 1153–1167.
   PubMed Web of Science ®Google Scholar
• Harigae, H., Suwabe, N., Weinstock, P.H., Nagai, M., Fujita, H., Yamamoto, M. and Sassa, S. (1998) "Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene", Blood 91, 798–805.
   PubMed Web of Science ®Google Scholar
• Furuyama, K., Fujita, H., Nagai, T., Yomogida, K., Munakata, H., Kondo, M., Kimura, A., Kuramoto, A., Hayashi, N. and Yamamoto, M. (1997) "Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroidc 5-aminolevulinate synthase gene", Blood 90, 822–830.
   PubMed Web of Science ®Google Scholar
• Cox, T.C., Bottomley, S.S., Wiley, J.S., Bawden, M.J., Matthews, C.S. and May, B.K. (1994) "X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to- Ser substitution in erythroid 5-aminolevulinate synthase", N. Engl. J. Med. 330, 675–679.
   PubMed Web of Science ®Google Scholar
• Cotter, P.D., Rucknagel, D.L. and Bishop, D.F. (1994) "X-linked sideroblastic anemia: identification of the mutation in the erythroidspecific delta-aminolevulinate synthase gene(ALAS2) in the original family described by Cooley", Blood 84, 3915–3924.
   PubMed Web of Science ®Google Scholar
• Prades, E., Chambon, C., Dailey, T.A., Dailey, H.A., Briere, J. and Grandchamp, B. (1995) "A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemia", Hum. Genet. 95, 424–428.
   PubMed Web of Science ®Google Scholar
• Spadaccini, A., Tilbrook, P.A., Sarna, M.K., Crossley, M., Bieker, J.J. and Klinken, S.P. (1998) "Transcription factor erythroid Kruppel-like factor (EKLF) is essential for the erythropoietininduced hemoglobin production but not for proliferation, viability, or morphological maturation", J. Biol. Chem. 273, 23793–23798.
   PubMed Web of Science ®Google Scholar
• Surinya, K.H., Cox, T.C. and May, B.K. (1997) "Transcriptional regulation of the human erythroid 5-aminolevulinate synthase gene. Identification of promoter elements and role of regulatory proteins", J. Biol. Chem. 272, 26585–26594.
   PubMed Web of Science ®Google Scholar
• Varone, C.L., Giono, L.E., Ochoa, A., Zakin, M.M. and Canepa, E.T. (1999) "Transcriptional regulation of 5-aminolevulinate synthase by phenobarbital and cAMP-dependent protein kinase", Arch. Biochem. Biophys. 372, 261–270.
   PubMed Web of Science ®Google Scholar
• Giono, L.E., Varone, C.L. and Canepa, E.T. (2001) "5-Aminolaevulinate synthase gene promoter contains two cAMP-response element (CRE)-like sites that confer positive and negative responsiveness to CRE-binding protein (CREB)", Biochem. J. 353, 307–316.
   PubMed Web of Science ®Google Scholar
• Garingo, A.D., Suhasini, M., rews, N.C. and Pilz, R.B. (1995) "cAMP-dependent protein kinase is necessary for increased NFE2. DNA complex formation during erythroleukemia cell differentiation", J. Biol. Chem. 270, 9169–9177.
   PubMed Web of Science ®Google Scholar
• Andrews, N.C., Erdjument-Bromage, H., Davidson, M.B., Tempst, P. and Orkin, S.H. (1993) "Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein", Nature 362, 722–728.
   PubMed Web of Science ®Google Scholar
• Andrews, N.C., Kotkow, K.J., Ney, P.A., Erdjument-Bromage, H., Tempst, P. and Orkin, S.H. (1993) "The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene", Proc. Natl Acad. Sci. USA 90, 11488–11492.
   PubMed Web of Science ®Google Scholar
• Forsberg, E.C., Downs, K.M. and Bresnick, E.H. (2000) "Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells", Blood 96, 334–339.
   PubMed Web of Science ®Google Scholar
• Goodwin, A.J., McInerney, J.M., Glander, M.A., Pomerantz, O. and Lowrey, C.H. (2001) "In vivo formation of a human betaglobin locus control region core element requires binding sites for multiple factors including GATA-1, NF-E2, erythroid Kruppellike factor, and Sp1", J. Biol. Chem. 276, 26883–26892.
   PubMed Web of Science ®Google Scholar
• Sawado, T., Igarashi, K. and Groudine, M. (2001) "Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter", Proc. Natl Acad. Sci. USA 98, 10226–10231.
   PubMed Web of Science ®Google Scholar
• Shivdasani, R.A. and Orkin, S.H. (1995) "Erythropoiesis and globin gene expression in mice lacking the transcription factor NFE2", Proc. Natl Acad. Sci. USA 92, 8690–8694.
   PubMed Web of Science ®Google Scholar
• Masuoka, H.C. and Townes, T.M. (2002) "Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice", Blood 99, 736–745.
   PubMed Web of Science ®Google Scholar
• Budillon, A., Cereseto, A., Kondrashin, A., Nesterova, M., Merlo, G., Clair, T. and Cho-Chung, Y.S. (1995) "Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts", Proc. Natl Acad. Sci. USA 92, 10634–10638.
   PubMed Web of Science ®Google Scholar
• Kim, S.H., Nairn, A.C., Cairns, N. and Lubec, G. (2001) "Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease", J. Neural Transm. Suppl., 263–272.
   PubMed Web of Science ®Google Scholar
• Stratakis, C.A. and Cho-Chung, Y.S. (2002) "Protein kinase A and human disease", Trends Endocrinol. Metab. 13, 50–52.
   PubMedGoogle Scholar
• Cho, Y.S., Kim, M.K., Tan, L., Srivastava, R., Agrawal, S. and Cho-Chung, Y.S. (2002) "Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation", Clin. Cancer Res. 8, 607–614.
   PubMed Web of Science ®Google Scholar
• Tortora, G. and Ciardiello, F. (2002) "Protein kinase A type I: a target for cancer therapy", Clin. Cancer Res. 8, 303–304.
   PubMed Web of Science ®Google Scholar
• Mauel, J., Ransijn, A., Corradin, S.B. and Buchmuller-Rouiller, Y. (1995) "Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha", J. Leukoc. Biol. 58, 217–224.
   PubMed Web of Science ®Google Scholar
• Verghese, M.W., McConnell, R.T., Strickland, A.B., Gooding, R.C., Stimpson, S.A., Yarnall, D.P., Taylor, J.D. and Furdon, P.J. (1995) "Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMPPDE) inhibitors", J. Pharmacol. Exp. Ther. 272, 1313–1320.
   PubMed Web of Science ®Google Scholar
• Claessens, Y.E., Bouscary, D., Dupont, J.M., Picard, F., Melle, J., Gisselbrecht, S., Lacombe, C., Dreyfus, F., Mayeux, P. and Fontenay-Roupie, M. (2002) "In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis", Blood 99, 1594–1601.
   PubMed Web of Science ®Google Scholar
• Sobulo, O.M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N.A., Rowley, J.D. and Zeleznik, L. (1997) "MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)", Proc. Natl Acad. Sci. USA 94, 8732–8737.
   PubMed Web of Science ®Google Scholar
• Kung, A.L., Rebel, V.I., Bronson, R.T., Ch'ng, L.E., Sieff, C.A., Livingston, D.M. and Yao, T.P. (2000) "Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP", Genes Dev. 14, 272–277.
   PubMed Web of Science ®Google Scholar
• Rebel, V.I., Kung, A.L. and Livingston, D.M. (2002) "Divergent roles for CREB-binding protein (CBP) and p300 in regulating hematopoietic stem cell self-renewal and differentiation", Blood 98(11), 78.
   Google Scholar
• Hung, H.L., Kim, A.Y., Hong, W., Rakowski, C. and Blobel, G.A. (2001) "Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation", J. Biol. Chem. 276, 10715–10721.
   PubMed Web of Science ®Google Scholar
• Pfitzner, E., Jahne, R., Wissler, M., Stoecklin, E. and Groner, B. (1998) "p300/CREB-binding protein enhances the prolactinmediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response", Mol. Endocrinol. 12, 1582–1593.
   PubMed Web of Science ®Google Scholar
• Shaywitz, A.J., Dove, S.L., Kornhauser, J.M., Hochschild, A. and Greenberg, M.E. (2000) "Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein", Mol. Cell Biol. 20, 9409–9422.
   PubMed Web of Science ®Google Scholar
• Antoni, F.A. (2000) "Molecular diversity of cyclic AMP signalling", Front Neuroendocrinol. 21, 103–132.
   PubMed Web of Science ®Google Scholar
• Bers, D.M. and Ziolo, M.T. (2001) "When is cAMP not cAMP? Effects of compartmentalization", Circ. Res. 89, 373–375.
   PubMed Web of Science ®Google Scholar